Proteinuria and other renal functions in Wilson's disease

Pediatric Nephrology

Volumn 11, Issue 3, 1997, Pages 307-311

  Sözeri, Emine ^a   Feist, Dietrich ^a   Ruder, Hans ^a   Schärer, Karl ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Calciuria; Copper metabolism; Hepatolenticular degeneration; Proteinuria; Tubular disorder; Wilson's disease

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; CALCIUM; CREATININE; N ACETYL BETA GLUCOSAMINIDASE; PENICILLAMINE; PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BETA 2 MICROGLOBULIN URINE LEVEL; CALCIUM URINE LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; HUMAN; KIDNEY FUNCTION; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; URINALYSIS; URINARY EXCRETION; WILSON DISEASE;

ACETYLGLUCOSAMINE; ADOLESCENT; CHELATING AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; GLOMERULAR FILTRATION RATE; HEPATOLENTICULAR DEGENERATION; HUMANS; INFANT; KIDNEY; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; MOLECULAR WEIGHT; PENICILLAMINE; PROTEINURIA;

EID: 0030907559     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670050282     Document Type: Article

References (38)

1. Danks DM (1991) Disorders of copper transport. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw Hill, New York, pp 1411 - 1431
2. Sokol RJ (1994) Wilson's disease and Indian childhood cirrhosis. In: Suchy FJ (ed) Liver disease in children. Mosby, St. Louis, pp 747-772
3. Scheinberg IH, Sternlieb I (1984) Wilson's disease. Saunders, Philadelphia, pp 1-171
4. Beam AG, Yü TF, Gutman AB (1957) Renal function in Wilson's disease. J Clin Invest 36: 1107- 1114
5. Huang CC, Chu NS (1992) Wilson's disease: clinical analysis of 71 cases and comparison with previous Chinese series J Formos Med Assoc 91: 502-507
6. Leu ML, Strickland GT, Gutman RA (1970) Renal function in Wilson's disease: response to penicillamine therapy. Am J Med Sci 260: 381 - 398
7. 2-microglobulin, albumin, and total protein. J Clin Invest 48: 1189 - 1198
8. Walshe JM (1968) Effect of penicillamine on failure of renal acidification in Wilson's disease. Lancet I: 775-778
9. Schonheyder F, Gregersen G, Hansen HE, Skov PE (1971) Renal clearances of different aminoacids in Wilson's disease before and after treatment with penicillamine. Acta Med Scand 190: 395-399
10. Elsas LJ, Hayslett JP, Spargo BH, Durant JL, Rosenberg LE (1971) Wilson's disease with reversible renal tubular dysfunction. Correlation with proximal tubular ultrastructure. Ann Intern Med 75: 427-433
11. Hall CL, Jawad D, Harrison PR, Mackenzie JC, Bacon PA, Klouda PT (1988) Natural course of penicillamine nephropathy: a long term study of 33 patients. B M J 296: 1083 - 1086
12. Feist D (1982) Die Wilson'sche Krankheit als hepatologisches Problem. Int Welt 5: 213 - 218
13. Feist D (1995) Neue Aspekte der Hepatologie im Kindesalter. Sozialpädiatrie 17: 276 - 279
14. Wartha R, Schärer K, Wollanka H, Schmidt H, Hasslacher C (1989) Patterns of proteinuria and urinary enzyme excretion in children and adolescents with diabetes mellitus. Pediatr Adolese Endocrinol 18: 133 - 148
15. Bradford MM (1976) A rapid and sensitive method for quantitation of microgram quantities of proteins utilizing the principle of protein dye binding. Anal Biochem 72: 248 - 254
16. Qoerg A, Postel W, Westermeier R, Righetti PG, Ek C (1982) One and two dimensional electrophoresis performed horizontally in ultrathin SDS pore-gradient gels. LKB application note 320. Bromma, Sweden
17. Ries M, Schärer K, Wartha R, Schmidt H, Gekle D (1991) Microheterogeneity of urinary albumin and tubular proteinuria in juvenile diabetes mellitus. Pediatr Nephrol 5: 582 - 586
18. Uzmann LL, Denny-Brown D (1948) Aminoaciduria in hepatolenticular degeneration (Wilson's disease). Am J Med Sci 260: 381 - 398
19. Bickel H, Neale FC, Hall G (1957) A clinical and biochemical study of hepatolenticular degeneration (Wilson's disease). Q J Med 26: 527 - 558
20. Hoppe B, Neuhaus T, Superti-Furga A, Forster I, Leumann E (1993) Hypercalciuria and nephrocalcinosis, a feature of Wilson's disease. Nephron 65: 460-462
21. Morgan HG, Stewart WK, Lome KG, Stowers JM, Johnstone JH (1962) Wilson's disease and the Fanconi syndrome. Q J Med 31: 361-384
22. Walshe JM (1969) Management of penicillamine nephropathy in Wilson's disease: a new chelating agent. Lancet II: 1401
23. Wolff SM (1964) Renal lesions in Wilson's disease. Lancet I: 843 - 845
24. Yoshitoshi Y, Oda T, Yamane Y, Nagase M, Mon K, Shikata T (1968) Renal lesions in Wilson's disease. Birth Defects 4: 104 - 108
25. Jaffe IA, Treiser G, Suzuki Y, Ehrenreich T (1968) Nephropathy induced by D-penicillamine. Ann Intern Med 69: 549-555
26. Reynolds ES, Tannen RL, Tyler HR (1966) The renal lesion in Wilson's disease. Am J Med 40: 518-527
27. Vogel FS (1960) Nephrotoxic properties of copper and experimental conditions in mice. Am J Pathol 36: 699-711
28. Hosovski E, Sunderic D, Sindjic M (1990) Functional and histologic changes in the kidney in copper poisoning in rats (in SerboCroatian). Srp Arh Celok Lek 118: 445 - 449
29. Lange (1967) Die Langzeitbehandlung des Morbus Wilson mit D-Penicillamin. Dtsch Med Wochenschr 92: 1657 - 1662
30. Lau JYN, Lai CL, Wu PC, Pan HYM, Lin HJ, Todd D (1990) Wilson's disease: 35 years experience. QJM 278: 597 - 605
31. Adams DA, Goldman R, Maxwell MH, Latta H (1964) Nephrotic syndrome associated with penicillamine therapy of Wilson's disease. Am J Med 36: 330 - 336
32. Sternlieb I, Scheinberg IH (1964) Penicillamine therapy for hepatolenticular degeneration. J Am Med Assoc 189: 748 - 754
33. Karp M, Lurie M, Yonis Z (1966) Nephrotic syndrome in the course of treatment of Wilson's disease with DL-penicillamine. Arch Dis Child 41: 684 - 688
34. Castellvi Suana JM, Xiol-Quingles X, Castellote Alonso J, Guardiola-Capon J (1993) Sindrome nefrosico secondaria a d-penicillamina en la enfermedad de Wilson. Rev Clin Esp 193: 343-344
35. Suda M, Kubota J, Yamaguchi F, Fujioka Y, Saito Y, Aoki T (1993) A study of trientine therapy in Wilson's disease with neurological symptoms. No To Hattatsu 25: 429-434
36. Nimm ME (1977) Mechanism of inhibition of collagen cross-linking by penicillamine. Proc R Soc Med 70 [Suppl 3]: 65
37. Khalil-Manesh F, Price RG (1983) Effect of D-penicillamine on glomerular basement membrane, urinary N-acetyl-β-D-glucosamindase and protein excretion in rats. Toxicology 26: 325 - 334
38. Herra SA, Hevia FJ, Vargas M, Schosinsky K (1990) Fulminant Wilson's disease in Costa Rica. Clinicopathological study of 7 cases (in Spanish). G E N 44: 9 - 14